Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?

作     者：Zhi-Bo Liu Wan-Mu Xie Zhen-Guo Zhai Bin Cao Jun Wan Liu Zhi-Bo;Xie Wan-Mu;Zhai Zhen-Guo;Cao Bin;Wan Jun

作者机构：Department of Pulmonary and Critical Care MedicineCenter of Respiratory MedicineChina-Japan Friendship Hospital/Institute of Respiratory MedicineChinese Academy of Medical Sciences/National Clinical Research Center for Respiratory DiseasesBeijing 100029China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2019年第132卷第14期

页      面：1742-1744页

核心收录：

学科分类：1002[医学-临床医学] 10[医学] 

基　　金：grants from the National Natural Science Foundation of China (No. 81270117) CAMS Innovation Fund for Medical Sciences (CIFMS)(No.2018-I2M-1-003). 

主　　题：pulmonary artery thrombosis pulmonary aspergillosis (PA) invasive pulmonary aspergillosis (IPA) subacute invasive pulmonary aspergillosis (SAIA) 

摘      要：Aspergillus is widespread in the environment and causes a variety of tracheobronchial and pulmonary disorders,depending upon the alterations of immune status of hosts.[1] Among the spectrum of pulmonary aspergillosis (PA),allergic bronchopulmonary aspergillosis,and most chronic pulmonary aspergillosis are considered as noninvasive diseases,whereas invasive pulmonary aspergillosis (IPA) and subacute invasive pulmonary aspergillosis (SAIA) may cause tissue invasion.